U K appeals court affirms HC ruling in Ranbaxy-Pfizer case
28 Jun 2006
![](ranbaxy_logo1.gif)
The three-judge panel confirmed that (Pfizer) Warner-Lambert's European Patent 409 281 was invalid in the UK. However, the company's atorvastatin product was ruled to infringe the broadest claims of (Pfizer) Warner-Lambert's European patent 247 633 in the UK. The company is evaluating this decision and will decide on its course of action shortly.